🇺🇸 FDA
Patent

US 11690825

20-HETE receptor (GPR75) antagonists and methods of use

granted A61KA61K31/197A61K31/201

Quick answer

US patent 11690825 (20-HETE receptor (GPR75) antagonists and methods of use) held by The Board of Regents of the University of Texas System expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/197, A61K31/201, A61K31/231, A61K31/41